Similar articles

• Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.

  Jounieaux V, Leleu O, Mayeux I. Jounieaux V, et al. Intensive Care Med. 2001 Jun;27(6):1103-4. doi: 10.1007/s001340100967. Intensive Care Med. 2001. PMID: 11497151 No abstract available.
• Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.

  Hwang TL, Wu CC, Teng CM. Hwang TL, et al. Br J Pharmacol. 1998 Nov;125(6):1158-63. doi: 10.1038/sj.bjp.0702181. Br J Pharmacol. 1998. PMID: 9863642 Free PMC article.
• Pyoderma gangrenosum treatment: a steroid-free option.

  Conwell P, Mikulski L, Moran D, Tramontozzi M. Conwell P, et al. Ostomy Wound Manage. 2004 May;50(5):26-8. Ostomy Wound Manage. 2004. PMID: 15379405 No abstract available.
• Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.

  Faber P, Ronald A, Millar BW. Faber P, et al. Anaesthesia. 2005 Jun;60(6):575-87. doi: 10.1111/j.1365-2044.2005.04185.x. Anaesthesia. 2005. PMID: 15918829 Review.
• Methylene blue for refractory hypotension: a case report.

  Weissgerber AJ. Weissgerber AJ. AANA J. 2008 Aug;76(4):271-4. AANA J. 2008. PMID: 18777811 Review.